Clinical Trials · NCT02176382

Denosumab and Teriparatide Study (DATA-HD and DATA-EX)

CompletedPhase 4Teriparatide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Massachusetts General Hospital
Enrollment
76
Start date
Aug 2014
Locations
1 site, United States
Primary endpoint
Percent Change From Baseline in Spine Bone Mineral Density by Dual X-ray Absorptiometry (DXA)
View Teriparatide compound reference